The disease is classified in hormonal breast cancer (the estrogenic receptor (ER) and/or progesterone receptor (PR) positive), human epidermal growth factor receptor 2 (HER2) positive, or triple-negative breast cancer (TNBC). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.